IP Library Granted Patent US 12,661,502
Granted Patent B2
US 12,661,502 · App. 17/536,355 · Granted Jun 23, 2026

Methods and apparatus for modifying or killing cells by manipulating the cell membrane charging time

Inventors: Michael Benjamin Sano (Cary, NC); Christopher Fesmire (Cary, NC); Ross A. Petrella (Richmond, VA)
Assignee: NORTH CAROLINA STATE UNIVERSITY
A61N1/306A61N1/325C12M35/04C12N15/87
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,661,502
App. No.
17/536,355
Filed
Nov 29, 2021
Granted
Jun 23, 2026
Kind
B2
Art Unit
3792
USPC
607/3
Abstract

A method of treatment includes modifying and/or killing cells by changing the cell membrane charging time to make the cells more susceptible to the influence of electric fields. The method may further include inserting one or more electrodes into tissue, acquiring a temperature of the tissue, delivering electrical energy to the tissue by electrical pulses, determining a rate of energy delivery of the electrical energy such that the temperature rises above a first critical temperature but remains below a second critical temperature, and delivering the electrical energy until a specific dose is achieved.

Claims (41)

1 . A method of treatment comprising modifying and/or killing a cell by changing a cell membrane charging time to make the cell more susceptible to an influence of an electric field,

wherein changing the cell membrane charging time comprises:

inserting one or more electrodes into or adjacent to tissue surrounding the cell;

acquiring a temperature of the tissue;

delivering, via the one or more electrodes, electrical energy to the tissue by a plurality of electrical pulses; and

increasing the temperature of the tissue using the electrical energy delivered to the tissue, to thereby change the cell membrane charging time,

wherein increasing the temperature of the tissue comprises dynamically controlling a rate of energy delivery of the electrical energy such that the temperature of the tissue rises above a first critical temperature and remains below a second critical temperature.

2 . The method of claim 1 , wherein changing the cell membrane charging time further comprises changing a response of a transmembrane potential due to the electrical pulses.

3 . The method of claim 1 , wherein modifying the cell comprises modifying a genome and/or a gene expression of the cell.

4 . The method of claim 1 , wherein modifying the cell comprises making it easier for drugs, nucleic acids, and/or molecules to cross the cell membrane.

5 . The method of claim 1 , wherein modifying the cell comprises making the cell a target of an immune system of a host of the cell.

6 . The method of claim 1 , wherein dynamically controlling the rate of energy delivery of the electrical energy such that the temperature of the tissue rises above the first critical temperature and remains below the second critical temperature comprises adjusting at least one of a time delay between ones of the electrical pulses, a width of one or more of the electrical pulses, or an amplitude of one or more of the electrical pulses.

7 . The method of claim 1 , wherein the temperature of the tissue is increased by at least 5° C. using the electrical energy.

8 . The method of claim 1 , wherein the rate of energy delivery of the electrical energy is dynamically controlled to increase the temperature of the tissue above the first critical temperature and to maintain the temperature of the tissue at a value between the first and second critical temperatures until an end of delivery of the electrical energy.

9 . The method of claim 1 , wherein the first critical temperature is between 37° C. and 55° C., and

wherein the second critical temperature is between 45° C. and 95° C.

10 . The method of claim 1 , wherein dynamically controlling the rate of energy delivery of the electrical energy such that the temperature of the tissue rises above the first critical temperature and remains below the second critical temperature comprises adjusting a duty cycle of the electrical pulses.

11 . The method of claim 1 , wherein dynamically controlling the rate of energy delivery of the electrical energy such that the temperature of the tissue rises above the first critical temperature and remains below the second critical temperature comprises adjusting a width of at least one of the electrical pulses.

12 . The method of claim 1 , wherein one or more of the electrical pulses are between 250 V and 10,000 V in amplitude.

13 . The method of claim 1 , wherein the electrical pulses comprise a positive polarity electrical pulse, followed by a first time delay, then a negative polarity pulse followed by a second time delay.

14 . The method of claim 13 , wherein the first time delay is equal to the second time delay and is between 100 ns and 100 μs in duration.

15 . The method of claim 13 , wherein the first time delay is shorter than the second time delay, and

wherein the first time delay is between 10 ns and 100 μs in duration, and the second time delay is between 10 μs and 10 seconds in duration.

16 . The method of claim 13 , wherein the first time delay is predetermined, and

wherein the second time delay is selected based on the temperature of the tissue.

17 . The method of claim 1 , further comprising delivering the electrical energy until a specific dose is achieved,

wherein the specific dose is calculated as a total number of the electrical pulses delivered, and

wherein the total number of the electrical pulses delivered is between 100 and 100,000 pulses.

18 . The method of claim 1 , wherein dynamically controlling the rate of energy delivery of the electrical energy such that the temperature of the tissue rises above the first critical temperature and remains below the second critical temperature comprises sequentially increasing widths of at least two consecutive electrical pulses among the plurality of electrical pulses.

19 . An apparatus for preventing, mitigating, and/or reducing tissue damage during a pulsed electric field therapy comprising a plurality of electrical pulses, the apparatus comprising circuitry configured to modify and/or kill a cell by changing a cell membrane charging time to make the cell more susceptible to an influence of an electric field,

wherein the apparatus comprises:

one or more electrodes configured to deliver electrical energy, via the electrical pulses, to tissue surrounding the cell; and

one or more temperature sensors configured to acquire a temperature of the tissue,

wherein the apparatus is configured to increase the temperature of the tissue using the electrical energy delivered to the tissue, to thereby change the cell membrane charging time, and

wherein the apparatus is configured to dynamically control a rate of energy delivery of the electrical energy such that the temperature of the tissue rises above a first critical temperature and remains below a second critical temperature.

20 . A method of treatment comprising modifying and/or killing a cell by changing a cell membrane charging time to make the cell more susceptible to an influence of an electric field,

wherein changing the cell membrane charging time comprises:

inserting one or more electrodes into or adjacent to tissue surrounding the cell;

delivering, via the one or more electrodes, electrical energy to the tissue by a plurality of electrical pulses; and

increasing a temperature of the tissue using the electrical energy delivered to the tissue, to thereby change the cell membrane charging time,

wherein a width of at least one of the electrical pulses is less than or equal to the cell membrane charging time.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 25, 2022
From: SANO, MICHAEL BENJAMIN; FESMIRE, CHRISTOPHER; PETRELLA, ROSS A.
To: NORTH CAROLINA STATE UNIVERSITY
Reel/Frame 059568/0535 →
Continuity (5)
Continuation In Part PCTUS2020035146 · May 29, 2020
Continuation In Part PCTUS2020035168 · May 29, 2020
Provisional Application 62855509 · May 31, 2019
Provisional Application 62855480 · May 31, 2019
Related Publication 20220080192A1 · Mar 17, 2022
References Cited (55)
US 5385544A · Edwards et al. · 1995 [cited by applicant]
US 6022316A · Eppstein · 2000 [cited by examiner]
US 20030225331A1 · Diederich et al. · 2003 [cited by applicant]
US 20050096584A1 · Ferek-Petric · 2005 [cited by applicant]
US 20120215213A1 · Juzkiw et al. · 2012 [cited by applicant]
US 20120215218A1 · Lipani · 2012 [cited by applicant]
US 20130253415A1 · Sano · 2013 [cited by examiner]
US 20140025064A1 · Collins et al. · 2014 [cited by applicant]
US 20150150618A1 · Onik et al. · 2015 [cited by applicant]
US 20160166310A1 · Stewart et al. · 2016 [cited by applicant]
US 20160166312A1 · Johnston · 2016 [cited by applicant]
US 20160184003A1 · Srimathveeravalli et al. · 2016 [cited by applicant]
US 20160324575A1 · Panescu et al. · 2016 [cited by applicant]
US 20160331441A1 · Konings · 2016 [cited by applicant]
US 20160367310A1 · Onik et al. · 2016 [cited by applicant]
US 20170035499A1 · Stewart et al. · 2017 [cited by applicant]
US 20170065343A1 · Mickelsen · 2017 [cited by applicant]
US 20170245928A1 · Xiao et al. · 2017 [cited by applicant]
US 20170266438A1 · Sano · 2017 [cited by examiner]
US 20170348525A1 · Sano et al. · 2017 [cited by applicant]
US 20170348539A1 · Schwarz et al. · 2017 [cited by applicant]
US 20180071014A1 · Neal et al. · 2018 [cited by applicant]
US 20180263685A1 · Onik et al. · 2018 [cited by applicant]
US 20180303543A1 · Stewart · 2018 [cited by examiner]
US 20210212753A1 · Sano et al. · 2021 [cited by applicant]
CN 87100574A · 1987 [cited by applicant]
CN 105283143A · 2016 [cited by applicant]
CN 105792883A · 2016 [cited by applicant]
WO 2007014003A2 · 2007 [cited by applicant]
WO 2018005511A1 · 2018 [cited by applicant]
WO 2019232358A1 · 2019 [cited by applicant]
“Cell membrane”, Wikipedia, retrieved from https://en.wikipedia.org/w/index.php?title=Cell_membrane&oldid=899062612 (6 pages) (May 27, 2019). [cited by applicant]
Al-Sakere et al. “Tumor ablation with irreversible electroporation” PloS One 2(11):e1135-e1135 (Nov. 2007). [cited by applicant]
Arena et al. “High-frequency irreversible electroporation (H-FIRE) for non-thermal ablation without muscle contraction” Biomed. Eng. Online 10:102-102 (2011). [cited by applicant]
Dong et al. “First Human Trial of High-Frequency Irreversible Electroporation Therapy for Prostate Cancer” Technol. Cancer Res. Treat. 17:1533033818789692-1533033818789692 (Jul. 2018). [cited by applicant]
El-Shabouri “Positively charged nanoparticles for improving the oral bioavailability of cyclosporin-A” Int. J. Pharm. 249(1):101-108 (Dec. 2002). [cited by applicant]
Hickey et al. “Control of polymeric nanoparticle size to improve therapeutic delivery” J. Control. Release Off. J. Control. Release Soc. 219:536-547 (Dec. 2015). [cited by applicant]
Kamaly et al. “Degradable Controlled-Release Polymers and Polymeric Nanoparticles: Mechanisms of Controlling Drug Release” Chem. Rev. 116(4):2602-2663 (Feb. 2016). [cited by applicant]
Notification of Transmittal of the International Search Report and the Written Opinion of the International Searching Authority, or the Declaration, in corresponding PCT Application No. PCT/US2020/035146 (11 pages) (Oct… [cited by applicant]
Notification of Transmittal of the International Search Report and the Written Opinion of the International Searching Authority, or the Declaration, in corresponding PCT Application No. PCT/US2020/035168 (22 pages) (Oct… [cited by applicant]
O'Brien et al. “Effects of internal electrode cooling on irreversible electroporation using a perfused organ model” Int. J. Hyperthermia 35:44-55 (2019). [cited by applicant]
Rogers et al. “Strength-duration curve for an electrically excitable tissue extended down to near 1 nanosecond” IEEE Transactions on Plasma Science 32(4):1587-1599 (2004). [cited by applicant]
Sano et al. “Burst and continuous high frequency irreversible electroporation protocols evaluated in a 3D tumor model” Phys. Med. Biol. 63(13):35022 (2018). [cited by applicant]
Sano et al. “Bursts of Bipolar Microsecond Pulses Inhibit Tumor Growth” Sci. Rep. 5:14999 (Oct. 2015). [cited by applicant]
Sano et al. “In-vitro bipolar nano- and microsecond electro-pulse bursts for irreversible electroporation therapies” Bioelectrochemistry 100:69-79 (2014). [cited by applicant]
Sano et al. “Production of Spherical Ablations Using Nonthermal Irreversible Electroporation: A Laboratory Investigation Using a Single Electrode and Grounding Pad” Spec. Issue Interv. Oncol. 27(9):1432-1440.e3 (Sep. 20… [cited by applicant]
Sano et al. “Reduction of Muscle Contractions during Irreversible Electroporation Therapy Using High Frequency Bursts of Alternating Polarity Pulses: A Laboratory Investigation in an Ex Vivo Swine Model” J Vasc Interv R… [cited by applicant]
Smith et al. “Active mechanisms are needed to describe cell responses to submicrosecond, megavolt-per-meter pulses: cell models for ultrashort pulses” Biophysical Journal 95:1547-1563 (2008). [cited by applicant]
Weaver et al. “A brief overview of electroporation pulse strength-duration space: a region where additional Intracellular effects are expected” Bioelectrochemistry 87:236-243 (2012). [cited by applicant]
Xia et al. “Salt-Induced Charge Screening and Significant Conductivity Enhancement of Conducting Poly(3,4-ethylenedioxythiophene):Poly(styrenesulfonate)” Macromolecules 42(12):4141-4147 (Jun. 2009). [cited by applicant]
Extended European Search Report Corresponding to European Application No. 20812651.6 (13 pages) (Jun. 1, 2023). [cited by applicant]
Fesmire et al. “Irreversible electroporation is a thermally mediated ablation modality for pulses on the order of one microsecond” Bioelectrochemistry (May 5, 2020). [cited by applicant]
Pucihar et al. “Equivalent Pulse Parameters for Electroporation” IEEE Transactions on Biomedical Engineering 58 (11) (Nov. 2011). [cited by applicant]
Retelj et al. “Electroporation of Intracellular Liposomes Using Nanosecond Electric Pulses—A Theoretical S” IEEE Transactions on Biomedical Engineering 60(9) (Sep. 2013). [cited by applicant]
“Chinese Office Action in Corresponding Application No. 2019800362501, mailed Mar. 30, 2024, 7 pages”. [cited by applicant]